Hematopoietic Stem Cells Transplantation Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: October 13, 2020 |

The global hematopoietic stem cells transplantation market size is projected to grow at a higher CAGR of 10.4% market during the forecast 2020-2027 and expected to reach up to $ 10,754.7 million in terms of revenue by 2025. Researchers have developed a tremendous understanding to use HSCs as a treatment therapy. At present, no type of stem cell, adult, embryonic, or fetal has attained such sufficient status. Through animal studies, researchers have observed that HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.

Market Insights:

The increasing prevalence of cancer and anemia in both developed and developing nations are the key growth factors in the hematopoietic stem cells transplantation market. In 2019, lymphoproliferative disorders and leukemia accounted for more than 50% of the market share. According to cancer research UK, leukemia is the 11th most common cancer worldwide which represented 2% of total cancer cases. Autologous HSCT has been preferred over allogeneic HSCT due to the absence of risk of graft versus host disease. The hematopoietic stem cell transplantation market is currently dominated by North America due to the increasing number of patients suffering from cancer and blood disorders, rising public awareness, and supportive reimbursement policies. On the other hand, Asia-Pacific is anticipated to be the fastest-growing market because of early disease diagnosis and treatment, increasing prevalence of blood disorders, medical tourism, and developing healthcare infrastructure.

Market Segment Insights:

The hematopoietic stem cells transplantation market is majorly segmented into applications such as (leukemia, lymphoproliferative disorders, solid tumors, and non-malignant disorders). Leukemia and lymphoproliferative disorders held the largest market in the applications segment chiefly due to factors like the increasing number of cancer patients, and blood disorders. The transplant type segment consists of (allogeneic transplant, and autologous transplant), the autologous HSCT held the largest market due to factors such as the absence of risk of graft versus host disease.

Global Hematopoietic Stem Cells Transplantation Market Segmentation:

By Application, 2018–2027 ($ Million)

  • Leukemia
  • Lymphoproliferative Disorders
  • Solid Tumors
  • Non-malignant Disorders

By Transplant Type, 2018–2027 ($ Million)

  • Autologous Transplant
  • Allogeneic Transplant

By Geography, 2018-2027 ($ Million)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Regional Insights:

North America, Latin America, Europe, Middle East & Africa, and Asia Pacific, markets together form the major regional markets for the hematopoietic stem cells transplantation market. These regional markets are further sub-segmented into country-specific markets on the basis of demand and market growth of the hematopoietic stem cells transplantation market. Among the considered regional markets, North America currently dominates the global hematopoietic stem cells transplantation market, with the United States being the largest country-level market. Increase in the number of patients suffering from blood disorders, rising public awareness, and supportive reimbursement policies.  On the other hand, Asia-Pacific is anticipated to be the fastest-growing market due to the huge population base suffering from blood cancer, medical tourism, and advanced healthcare infrastructure.

Market Competition Assessment:

Key players in the global hematopoietic stem cells transplantation market are CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., Genlantis, Kite Pharma Inc., Lonza Group Ltd., Pluristem Therapeutics Inc., PromoCell GmbH, R&D Systems, ScienCell research laboratories, Stempuetics Research Pvt. Ltd., Takara Bio, Thermo Fisher Scientific, TiGenix N.V.

List of Key Companies:

  • CellGenix Technologie Transfer GmbH
  • Cesca Therapeutics Inc.
  • Escape Therapeutics
  • Genlantis
  • Kite Pharma Inc.
  • Lonza Group
  • PromoCell GmbH
  • Pluristem Therapeutics Inc.
  • R&D Systems
  • ScienCell Research Laboratories
  • Stempuetics Research Pvt. Ltd.
  • Takara Bio
  • Thermo Fisher Scientific, Inc.
  • TiGenix N.V.

Key Questions Answered by Hematopoietic Stem Cells Transplantation Market Report

  • Global hematopoietic stem cells transplantation market forecasts from 2020-2027
  • Regional hematopoietic stem cells transplantation market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
  • Hematopoietic Stem Cells Transplantation submarket forecasts from 2020-2027 covering the market by transplant type, by application, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to the hematopoietic stem cells transplantation market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level hematopoietic stem cells transplantation markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the hematopoietic stem cells transplantation market

Request a full report sample in PDF format @ https://www.researchcorridor.com/request-sample/?id=91776


Table of Content:


Chapter 1 Preface


1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary


2.1 Global Hematopoietic Stem Cell Transplantation Market, by Transplantation Type, 2019($ Million)
2.2 Global Hematopoietic Stem Cell Transplantation Market, by Application Type, 2019 ($ Million)
2.3 Global Hematopoietic Stem Cell Transplantation Market, by Geography, 2019 (Value %)

Chapter 3 Global Hematopoietic Stem Cells Transplantation Market Overview


3.1 Overview
3.2 Market Drivers
3.2.1 Increasing Prevalence of Blood Cancer
3.2.2 Better Survival Rates
3.3 Market Restraints
3.3.1 Technical Challenges for Engineering Synthetic HSC Niches at the Nano scale
3.3.2 Infectious Complications of Hematopoietic Stem Cell Transplantation
3.4 Market Opportunities
3.4.1 Future in Regenerative Stromal Cell Therapy
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Hematopoietic Stem Cells Transplantation Market, by Key Players

Chapter 4 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Transplant Type, 2018-2027 ($ Million)


4.1 Overview
4.2 Autologous Transplant
4.3 Allogeneic Transplant

Chapter 5 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Applications, 2018-2027 ($ Million)


5.1 Overview
5.2 Leukemia
5.3 Lymphoproliferative Disorders
5.4 Solid Tumors
5.5 Non-malignant Disorders

Chapter 6 Global Hematopoietic Stem Cells Market, by Geography, 2018-2027 ($ Million)


6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.2. Europe
6.2.1. U.K.
6.2.2. Germany
6.2.3. Rest of Europe
6.3. Asia Pacific
6.3.1. Japan
6.3.2. China
6.3.3. Rest of Asia Pacific
6.4. Latin America
6.4.1. Mexico
6.4.2. Brazil
6.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. GCC
6.5.2. Rest of Middle East and Africa

Chapter 7 Company Profiles


7.1. CellGenix Technologie Transfer GmbH
7.2. Cesca Therapeutics Inc.
7.3. Escape Therapeutics
7.4. Genlantis
7.5. Kite Pharma Inc.
7.6. Lonza Group
7.7. PromoCell GmbH
7.8. Pluristem Therapeutics Inc.
7.9. R&D Systems
7.10. ScienCell Research Laboratories
7.11. Stempuetics Research Pvt. Ltd.
7.12. Takara Bio
7.13. Thermo Fisher Scientific, Inc.
7.14. TiGenix N.V.

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
Fill the given form to request sample for Hematopoietic Stem Cells Transplantation Market Report

Your Designtaion (required):

Fill the given form to inquiry before buying for Hematopoietic Stem Cells Transplantation Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com